| Insideraktier | 7.464.864 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Sierra Oncology Inc insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i SRRA / Sierra Oncology Inc. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i SRRA / Sierra Oncology Inc. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-01 | 2022-07-01 | 4 | Vivo Opportunity, LLC By: Vivo Capital Fund IX, L.P. | SRRA | Common Stock | I | 55,0000 | -431.947 | -23.757 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Vivo Opportunity, LLC By: Vivo Opportunity Fund Holdings, L.P. | SRRA | Common Stock | I | 55,0000 | -2.735.853 | -150.472 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Vivo Opportunity, LLC By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 55,0000 | -161.712 | -8.894 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | ORBIMED ADVISORS LLC See footnotes | SRRA | Common Stock | I | 55,0000 | -226.704 | -12.469 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | ORBIMED ADVISORS LLC See footnotes | SRRA | Common Stock | I | 55,0000 | -226.704 | -12.469 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | ORBIMED ADVISORS LLC See footnotes | SRRA | Common Stock | I | 55,0000 | -1.511.362 | -83.125 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Ashiya Mona See footnotes | SRRA | Common Stock | I | 55,0000 | -226.704 | -12.469 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Ashiya Mona See footnotes | SRRA | Common Stock | I | 55,0000 | -226.704 | -12.469 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Ashiya Mona See footnotes | SRRA | Common Stock | I | 55,0000 | -1.511.362 | -83.125 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Aggarwal Gaurav By: Vivo Opportunity Fund Holdings, L.P. | SRRA | Common Stock | I | 55,0000 | -2.735.853 | -150.472 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Klencke Barbara By spouse | SRRA | Common Stock | I | 55,0000 | -5.000 | -275 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Klencke Barbara | SRRA | Common Stock | D | 55,0000 | -10.000 | -550 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Sinclair Andrew See footnotes | SRRA | Common Stock, $0.001 par value | I | 55,0000 | -1.314.127 | -72.277 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Allen Andrew R | SRRA | Common Stock | D | 55,0000 | -1.650 | -91 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | Collard Craig A | SRRA | Common Stock | D | 55,0000 | -13.500 | -742 | 0 | ||||
| 2022-07-01 | 2022-07-01 | 4 | DILLY STEPHEN GEORGE | SRRA | Common Stock | D | 55,0000 | -5.000 | -275 | 0 | ||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 840 | 8.015 | ||||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 252 | 2.404 | ||||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 588 | 5.611 | ||||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 7.175 | 7.175 | ||||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 2.152 | 2.152 | ||||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 5.023 | 5.023 | ||||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | -1.964.771 | 0 | ||||||
| 2022-04-29 | 2022-04-27 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | -175.000 | 0 | ||||||
| 2022-04-07 | 2022-04-06 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 12,05 | 6.347 | 0 | |||||
| 2022-04-07 | 2022-04-06 | 4 | Turner William D. | SRRA | Common Stock | D | 37,2474 | -6.347 | -236 | 0 | ||||
| 2022-04-07 | 2022-04-06 | 4 | Turner William D. | SRRA | Common Stock | D | 12,0500 | 6.347 | 76 | 6.347 | ||||
| 2022-04-07 | 2022-04-05 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 12,05 | 100 | 0 | |||||
| 2022-04-07 | 2022-04-05 | 4 | Turner William D. | SRRA | Common Stock | D | 37,0900 | -100 | -4 | 0 | ||||
| 2022-04-07 | 2022-04-05 | 4 | Turner William D. | SRRA | Common Stock | D | 12,0500 | 100 | 1 | 100 | ||||
| 2022-04-04 | 2022-04-04 | 4 | Thomson Mary Christina | SRRA | Stock Option (Right to Buy) | D | 13,04 | 2.000 | 0 | |||||
| 2022-04-04 | 2022-04-04 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 35,1384 | -2.000 | -70 | 0 | ||||
| 2022-04-04 | 2022-04-04 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 13,0400 | 2.000 | 26 | 2.000 | ||||
| 2022-03-22 | 2022-03-18 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 12,05 | 100 | 0 | |||||
| 2022-03-22 | 2022-03-18 | 4 | Turner William D. | SRRA | Common Stock | D | 37,0500 | -100 | -4 | 0 | ||||
| 2022-03-22 | 2022-03-18 | 4 | Turner William D. | SRRA | Common Stock | D | 12,0500 | 100 | 1 | 100 | ||||
| 2022-03-17 | 2022-03-17 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 12,05 | 3.453 | 0 | |||||
| 2022-03-17 | 2022-03-17 | 4 | Turner William D. | SRRA | Common Stock | D | 37,0558 | -3.453 | -128 | 0 | ||||
| 2022-03-17 | 2022-03-17 | 4 | Turner William D. | SRRA | Common Stock | D | 12,0500 | 3.453 | 42 | 3.453 | ||||
| 2022-03-14 | 2022-03-14 | 4 | DILLY STEPHEN GEORGE | SRRA | Stock Option (Right to Buy) | D | 31,54 | 165.000 | 165.000 | |||||
| 2022-03-14 | 2022-03-14 | 4 | Jagpal Sukhi | SRRA | Stock Option (Right to Buy) | D | 31,54 | 50.000 | 50.000 | |||||
| 2022-03-14 | 2022-03-14 | 4 | Klencke Barbara | SRRA | Stock Option (Right to Buy) | D | 31,54 | 50.000 | 50.000 | |||||
| 2022-03-14 | 2022-03-14 | 4 | Norrett Kevin | SRRA | Stock Option (Right to Buy) | D | 31,54 | 35.000 | 35.000 | |||||
| 2022-03-14 | 2022-03-14 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 31,54 | 35.000 | 35.000 | |||||
| 2022-03-14 | 2022-03-14 | 4 | Thomson Mary Christina | SRRA | Stock Option (Right to Buy) | D | 31,54 | 35.000 | 35.000 | |||||
| 2022-03-04 | 2022-03-04 | 4 | Thomson Mary Christina | SRRA | Stock Option (Right to Buy) | D | 13,04 | 2.000 | 0 | |||||
| 2022-03-04 | 2022-03-04 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 30,5981 | -2.000 | -61 | 0 | ||||
| 2022-03-04 | 2022-03-04 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 13,0400 | 2.000 | 26 | 2.000 | ||||
| 2022-02-08 | 2022-02-07 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 12,05 | 10.000 | 0 | |||||
| 2022-02-08 | 2022-02-07 | 4 | Turner William D. | SRRA | Common Stock | D | 32,3225 | -10.000 | -323 | 0 | ||||
| 2022-02-08 | 2022-02-07 | 4 | Turner William D. | SRRA | Common Stock | D | 12,0500 | 10.000 | 120 | 10.000 | ||||
| 2022-02-04 | 2022-02-04 | 4 | Thomson Mary Christina | SRRA | Stock Option (Right to Buy) | D | 13,04 | 2.000 | 0 | |||||
| 2022-02-04 | 2022-02-04 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 29,7800 | -2.000 | -60 | 0 | ||||
| 2022-02-04 | 2022-02-04 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 13,0400 | 2.000 | 26 | 2.000 | ||||
| 2022-02-02 | 2022-02-02 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 27,0000 | 175.000 | 4.725 | 175.000 | ||||
| 2022-02-02 | 2022-02-02 | 4 | Richardson Joshua | SRRA | Common Stock | I | 27,0000 | 175.000 | 4.725 | 175.000 | ||||
| 2022-02-02 | 3 | Longitude Prime Fund, L.P. | SRRA | Common Stock | I | 175.000 | ||||||||
| 2022-02-01 | 2022-01-31 | 4 | Sinclair Andrew See footnotes | SRRA | Common Stock, $0.001 par value | I | 27,0000 | 150.000 | 4.050 | 1.314.127 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Sinclair Andrew See footnotes | SRRA | Series B Warrants (right to buy) | I | 13,20 | -287.471 | 0 | |||||
| 2022-02-01 | 2022-01-28 | 4 | Sinclair Andrew See footnotes | SRRA | Common Stock, $0.001 par value | I | 13,2000 | 287.471 | 3.795 | 1.164.127 | ||||
| 2022-02-01 | 2022-01-31 | 4 | Abingworth LLP | SRRA | Common Stock, $0.001 par value | I | 27,0000 | 150.000 | 4.050 | 1.314.127 | ||||
| 2022-02-01 | 2022-01-28 | 4 | Abingworth LLP | SRRA | Series B Warrants (right to buy) | I | 13,20 | -287.471 | 0 | |||||
| 2022-02-01 | 2022-01-28 | 4 | Abingworth LLP | SRRA | Common Stock, $0.001 par value | I | 13,2000 | 287.471 | 3.795 | 1.164.127 | ||||
| 2022-01-31 | 2022-01-31 | 4 | Vivo Opportunity, LLC By Vivo Opportunity Fund, L.P. | SRRA | Common Stock | I | 27,0000 | 800.000 | 21.600 | 2.735.853 | ||||
| 2022-01-31 | 2022-01-31 | 4 | Aggarwal Gaurav By Vivo Opportunity Fund, L.P. | SRRA | Common Stock | I | 27,0000 | 800.000 | 21.600 | 2.735.853 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Ashiya Mona See footnotes | SRRA | Series B Warrants | I | 13,20 | -56.244 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Ashiya Mona See footnotes | SRRA | Series B Warrants | I | 13,20 | -56.244 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Ashiya Mona See footnotes | SRRA | Series B Warrants | I | 13,20 | -374.962 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Ashiya Mona See footnotes (4), | SRRA | Common Stock | I | 13,2000 | 56.244 | 742 | 226.704 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Ashiya Mona See footnotes | SRRA | Common Stock | I | 13,2000 | 56.244 | 742 | 226.704 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Ashiya Mona See footnotes (4), | SRRA | Common Stock | I | 13,2000 | 374.962 | 4.949 | 1.511.362 | ||||
| 2022-01-28 | 2022-01-26 | 4 | ORBIMED ADVISORS LLC | SRRA | Series B Warrants | I | 13,20 | -56.244 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | ORBIMED ADVISORS LLC | SRRA | Series B Warrants | I | 13,20 | -56.244 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | ORBIMED ADVISORS LLC | SRRA | Series B Warrants | I | 13,20 | -374.962 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | ORBIMED ADVISORS LLC | SRRA | Common Stock | I | 13,2000 | 56.244 | 742 | 226.704 | ||||
| 2022-01-28 | 2022-01-26 | 4 | ORBIMED ADVISORS LLC See footnote (4), | SRRA | Common Stock | I | 13,2000 | 56.244 | 742 | 226.704 | ||||
| 2022-01-28 | 2022-01-26 | 4 | ORBIMED ADVISORS LLC See footnote (4), | SRRA | Common Stock | I | 13,2000 | 374.962 | 4.949 | 1.511.362 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Vivo Opportunity, LLC By: Vivo Capital Fund IX, L.P. | SRRA | Series B Warrant (Right to Purchase ) | I | 13,20 | 13,2000 | -324.740 | -4.287 | 0 | |||
| 2022-01-28 | 2022-01-26 | 4 | Vivo Opportunity, LLC By: Vivo Opportunity Fund, L.P. | SRRA | Series B Warrant (Right to Purchase ) | I | 13,20 | 13,2000 | -1.455.384 | -19.211 | 0 | |||
| 2022-01-28 | 2022-01-26 | 4 | Vivo Opportunity, LLC By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Series B Warrant (Right to Purchase ) | I | 13,20 | 13,2000 | -75.749 | -1.000 | 0 | |||
| 2022-01-28 | 2022-01-26 | 4 | Vivo Opportunity, LLC By: Vivo Capital Fund IX, L.P. | SRRA | Common Stock | I | 13,2000 | 107.164 | 1.415 | 431.947 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Vivo Opportunity, LLC By: Vivo Opportunity Fund, L.P. | SRRA | Common Stock | I | 13,2000 | 480.277 | 6.340 | 1.935.853 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Vivo Opportunity, LLC By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 13,2000 | 24.996 | 330 | 161.712 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Aggarwal Gaurav By Vivo Opportunity Fund, L.P. | SRRA | Series B Warrant (Right to Purchase) | I | 13,20 | 13,2000 | -1.455.384 | -19.211 | 0 | |||
| 2022-01-28 | 2022-01-26 | 4 | Aggarwal Gaurav By Vivo Opportunity Fund, L.P. | SRRA | Common Stock | I | 13,2000 | 480.277 | 6.340 | 1.935.853 | ||||
| 2022-01-28 | 2022-01-28 | 4 | Klencke Barbara | SRRA | Stock Option (Right to Buy) | D | 12,15 | 12.250 | 12.250 | |||||
| 2022-01-28 | 2022-01-28 | 4 | Kowalski Mark | SRRA | Stock Option (Right to Buy) | D | 12,15 | 12.250 | 12.250 | |||||
| 2022-01-28 | 2022-01-28 | 4 | Norrett Kevin | SRRA | Stock Option (Right to Buy) | D | 12,15 | 12.250 | 12.250 | |||||
| 2022-01-28 | 2022-01-28 | 4 | DILLY STEPHEN GEORGE | SRRA | Stock Option (Right to Buy) | D | 12,15 | 65.000 | 65.000 | |||||
| 2022-01-28 | 2022-01-28 | 4 | Jagpal Sukhi | SRRA | Stock Option (Right to Buy) | D | 12,15 | 12.250 | 12.250 | |||||
| 2022-01-28 | 2022-01-28 | 4 | Thomson Mary Christina | SRRA | Stock Option (Right to Buy) | D | 12,15 | 12.250 | 12.250 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Thomson Mary Christina | SRRA | Stock Option (Right to Buy) | D | 13,04 | 2.000 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 29,0000 | -2.000 | -58 | 0 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Thomson Mary Christina | SRRA | Common Stock | D | 13,0400 | 2.000 | 26 | 2.000 | ||||
| 2022-01-28 | 2022-01-28 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 12,15 | 12.250 | 12.250 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 12,05 | 5.000 | 0 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Turner William D. | SRRA | Common Stock | D | 27,0500 | -5.000 | -135 | 0 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Turner William D. | SRRA | Common Stock | D | 12,0500 | 5.000 | 60 | 5.000 | ||||
| 2022-01-27 | 2022-01-25 | 4 | Longitude Capital Partners III, LLC | SRRA | Series B Warrants | I | 13,20 | 13,2000 | -1.477.125 | -19.498 | 0 | |||
| 2022-01-27 | 2022-01-25 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 13,2000 | 487.451 | 6.434 | 1.964.771 | ||||
| 2022-01-27 | 2022-01-25 | 4 | Richardson Joshua By Longitude Venture Partners III, L.P. | SRRA | Series B Warrants | I | 13,20 | 13,2000 | -1.477.125 | -19.498 | 0 | |||
| 2022-01-27 | 2022-01-25 | 4 | Richardson Joshua By Longitude Venture Partners III, L.P. | SRRA | Common Stock | I | 13,2000 | 487.451 | 6.434 | 1.964.771 | ||||
| 2021-11-24 | 2021-11-24 | 4 | Collard Craig A | SRRA | Common Stock | D | 23,0850 | 7.899 | 182 | 13.500 | ||||
| 2021-11-24 | 2021-11-23 | 4 | Collard Craig A | SRRA | Common Stock | D | 22,9450 | 5.601 | 129 | 5.601 | ||||
| 2021-11-05 | 3 | Abingworth LLP | SRRA | Common Stock, $0.001 par value | I | 878.656 | ||||||||
| 2021-06-28 | 2021-03-15 | 4 | Thomson Mary Christina | SRRA | Stock Option (Right to Buy) | D | 16,73 | 12.900 | 12.900 | |||||
| 2021-06-28 | 2020-07-28 | 4 | Thomson Mary Christina | SRRA | Stock option (right to buy) | D | 13,04 | 100.000 | 100.000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Cooper Jeffrey H | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6.000 | 6.000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Collard Craig A | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6.000 | 6.000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Pelzer Robert | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6.000 | 6.000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Ashiya Mona | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6.000 | 6.000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Allen Andrew R | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6.000 | 6.000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Aggarwal Gaurav | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6.000 | 6.000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Sinclair Andrew | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6.000 | 6.000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Richardson Joshua | SRRA | Stock Option (Right To Buy) | D | 18,11 | 6.000 | 6.000 | |||||
| 2021-06-04 | 2021-06-02 | 4 | Oliger Christy J. | SRRA | Stock Option (right to buy) | D | 17,76 | 18.000 | 18.000 | |||||
| 2021-06-04 | 2021-06-02 | 4 | Erbez Georgia | SRRA | Stock Option (right to buy) | D | 17,76 | 18.000 | 18.000 | |||||
| 2021-05-20 | 2021-05-19 | 4 | DILLY STEPHEN GEORGE | SRRA | Common Stock | D | 17,8300 | 5.000 | 89 | 5.000 | ||||
| 2021-03-17 | 2021-03-15 | 4 | Turner William D. | SRRA | Stock Option (Right to Buy) | D | 16,73 | 12.300 | 12.300 | |||||
| 2021-03-17 | 2021-03-15 | 4 | Thomson Christina | SRRA | Stock Option (Right to Buy) | D | 16,73 | 12.900 | 12.900 | |||||
| 2021-03-17 | 2021-03-15 | 4 | Norrett Kevin | SRRA | Stock Option (Right to Buy) | D | 16,73 | 11.700 | 11.700 | |||||
| 2021-03-17 | 2021-03-15 | 4 | Kowalski Mark | SRRA | Stock Option (Right to Buy) | D | 16,73 | 30.000 | 30.000 | |||||
| 2021-03-17 | 2021-03-15 | 4 | Jagpal Sukhi | SRRA | Stock Option (Right to Buy) | D | 16,73 | 30.000 | 30.000 | |||||
| 2021-03-17 | 2021-03-15 | 4 | Klencke Barbara | SRRA | Stock Option (Right to Buy) | D | 16,73 | 30.000 | 30.000 | |||||
| 2021-03-17 | 2021-03-15 | 4 | DILLY STEPHEN GEORGE | SRRA | Stock Option (Right to Buy) | D | 16,73 | 92.000 | 92.000 | |||||
| 2020-08-18 | 2020-08-18 | 4 | Klencke Barbara By spouse | SRRA | Common Stock | I | 12,2519 | 3.325 | 41 | 5.000 | ||||
| 2020-08-18 | 2020-08-18 | 4 | Klencke Barbara | SRRA | Common Stock | D | 12,2201 | 5.950 | 73 | 10.000 | ||||
| 2020-08-12 | 2020-08-12 | 4 | Jagpal Sukhi | SRRA | Stock Option (right to buy) | D | 12,15 | 5.887 | 5.887 | |||||
| 2020-08-12 | 2020-08-12 | 4 | Kowalski Mark | SRRA | Stock Option (right to buy) | D | 12,15 | 24.970 | 24.970 | |||||
| 2020-08-11 | 2020-08-10 | 4 | Norrett Kevin | SRRA | Stock option (right to buy) | D | 12,05 | 100.000 | 100.000 | |||||
| 2020-08-06 | 2020-08-04 | 4 | Turner William D. | SRRA | Stock option (right to buy) | D | 12,05 | 100.000 | 100.000 | |||||
| 2020-07-29 | 2020-07-28 | 4 | Thomson Christina | SRRA | Stock option (right to buy) | D | 13,04 | 100.000 | 100.000 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Aggarwal Gaurav | SRRA | Stock Option (right to buy) | D | 13,98 | 6.874 | 6.874 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Allen Andrew R | SRRA | Stock Option (right to buy) | D | 13,98 | 12.030 | 12.030 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Ashiya Mona | SRRA | Stock Option (right to buy) | D | 13,98 | 6.874 | 6.874 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Cooper Jeffrey H | SRRA | Stock Option (right to buy) | D | 13,98 | 18.061 | 18.061 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Pelzer Robert | SRRA | Stock Option (right to buy) | D | 13,98 | 16.686 | 16.686 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Richardson Joshua | SRRA | Stock Option (right to buy) | D | 13,98 | 6.874 | 6.874 | |||||
| 2020-06-10 | 2020-06-09 | 4 | Sinclair Andrew | SRRA | Stock Option (right to buy | D | 13,98 | 6.874 | 6.874 | |||||
| 2020-06-02 | 2020-06-01 | 4 | DILLY STEPHEN GEORGE | SRRA | Stock Option (right to buy) | D | 14,03 | 520.000 | 520.000 | |||||
| 2020-05-29 | 2020-05-28 | 4 | Collard Craig A | SRRA | Stock Option (right to buy) | D | 13,88 | 10.000 | 10.000 | |||||
| 2020-02-27 | 2020-02-25 | 4 | Glover Nicholas | SRRA | Stock Option (right to buy) | D | 13,31 | 359.158 | 359.158 | |||||
| 2020-02-27 | 2020-02-25 | 4 | Jagpal Sukhi | SRRA | Stock Option (right to buy) | D | 13,31 | 94.113 | 94.113 | |||||
| 2020-02-27 | 2020-02-25 | 4 | Klencke Barbara | SRRA | Stock Option (right to buy) | D | 13,31 | 167.091 | 167.091 | |||||
| 2020-02-27 | 2020-02-25 | 4 | Kowalski Mark | SRRA | Stock Option (right to buy) | D | 13,31 | 75.030 | 75.030 | |||||
| 2020-02-03 | 2020-01-29 | 4/A | Sinclair Andrew See footnotes | SRRA | Series A Convertible Voting Preferred Stock | I | -11.500 | 0 | ||||||
| 2020-02-03 | 2020-01-29 | 4/A | Sinclair Andrew See footnotes | SRRA | Common Stock | I | 871.240 | 876.656 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | ORBIMED ADVISORS LLC See footnotes | SRRA | Series A Convertible Voting Preferred Stock | I | -19.500 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | ORBIMED ADVISORS LLC See footnotes | SRRA | Common Stock | I | 1.477.320 | 1.477.320 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Aggarwal Gaurav By Vivo Opportunity Fund, LP | SRRA | Series A Convertible Voting Preferred Stock | I | -19.213 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Aggarwal Gaurav By Vivo Opportunity Fund, LP | SRRA | Common Stock | I | 1.455.576 | 1.455.576 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Ashiya Mona See footnotes | SRRA | Series A Convertible Voting Preferred Stock | I | -19.500 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Ashiya Mona See footnotes | SRRA | Common Stock | I | 1.477.320 | 1.477.320 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Richardson Joshua By Longitude Venture Partners III, L.P. | SRRA | Series A Convertible Voting Preferred Stock | I | -19.500 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Richardson Joshua By Longitude Venture Partners III, L.P. | SRRA | Common Stock | I | 1.477.320 | 1.477.320 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Longitude Capital Partners III, LLC | SRRA | Series A Convertible Voting Preferred Stock | I | -19.500 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Longitude Capital Partners III, LLC | SRRA | Common Stock | I | 1.477.320 | 1.477.320 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Vivo Opportunity, LLC By: Vivo Capital Fund IX, L.P. | SRRA | Series A Convertible Voting Preferred Stock | I | -4.287 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Vivo Opportunity, LLC By Vivo Opportunity Fund, L.P. | SRRA | Series A Convertible Voting Preferred Stock | I | -19.213 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Vivo Opportunity, LLC By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Series A Convertible Voting Preferred Stock | I | -1.000 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Vivo Opportunity, LLC By: Vivo Capital Fund IX, L.P. | SRRA | Common Stock | I | 324.783 | 324.783 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Vivo Opportunity, LLC By Vivo Opportunity Fund, L.P. | SRRA | Common Stock | I | 1.455.576 | 1.455.576 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Vivo Opportunity, LLC By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 75.759 | 136.715 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Sinclair Andrew See footnotes | SRRA | Series A Convertible Voting Preferred Stock | I | -11.500 | 0 | ||||||
| 2020-01-31 | 2020-01-29 | 4 | Sinclair Andrew See footnotes | SRRA | Common Stock | I | 871.125 | 876.542 | ||||||
| 2019-12-03 | 2019-11-29 | 4 | Sinclair Andrew | SRRA | Stock Option (right to buy) | D | 0,35 | 60.000 | 60.000 | |||||
| 2019-12-03 | 2019-11-29 | 4 | Aggarwal Gaurav | SRRA | Stock Option (Right to Buy) | D | 0,35 | 60.000 | 60.000 | |||||
| 2019-12-03 | 2019-11-29 | 4 | Ashiya Mona | SRRA | Stock Option (Right to Buy) | D | 0,35 | 60.000 | 60.000 | |||||
| 2019-12-03 | 2019-11-29 | 4 | Richardson Joshua | SRRA | Stock Option (Right to Buy) | D | 0,35 | 60.000 | 60.000 | |||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4.876.540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4.876.540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4.876.540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4.876.540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4.876.540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4.876.540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4.876.540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4.876.540 | ||||||||
| 2019-12-02 | 3 | Vivo Ventures VII Affiliates Fund, L.P. By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P. | SRRA | Common Stock | I | 4.876.540 | ||||||||
| 2019-11-26 | 3 | Sinclair Andrew See Footnotes | SRRA | Common Stock, $0.001 par value | I | 433.334 | ||||||||
| 2019-11-26 | 3 | Sinclair Andrew See Footnotes | SRRA | Common Stock, $0.001 par value | I | 433.334 | ||||||||
| 2019-11-26 | 3 | Sinclair Andrew See Footnotes | SRRA | Common Stock, $0.001 par value | I | 433.334 | ||||||||
| 2019-08-26 | 2019-08-23 | 4 | Klencke Barbara | SRRA | Common Stock | D | 0,4387 | 108.000 | 47 | 162.000 | ||||
| 2019-08-26 | 2019-08-22 | 4 | Klencke Barbara | SRRA | Common Stock | D | 0,4499 | 54.000 | 24 | 54.000 | ||||
| 2019-08-26 | 2019-08-22 | 4 | Klencke Barbara By spouse | SRRA | Common Stock | I | 0,4323 | 67.000 | 29 | 67.000 | ||||
| 2019-06-12 | 2019-06-11 | 4 | Cooper Jeffrey H | SRRA | Stock Option (right to buy) | D | 0,66 | 30.000 | 30.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | ESTES DANIEL | SRRA | Stock Option (right to buy) | D | 0,66 | 30.000 | 30.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Nguyen Tran | SRRA | Stock Option (right to buy) | D | 0,66 | 30.000 | 30.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | ONETTO NICOLE | SRRA | Stock Option (right to buy) | D | 0,66 | 30.000 | 30.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Parfet Donald R | SRRA | Stock Option (right to buy) | D | 0,66 | 30.000 | 30.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Pelzer Robert | SRRA | Stock Option (right to buy) | D | 0,66 | 30.000 | 30.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Allen Andrew R | SRRA | Stock Option (right to buy) | D | 0,66 | 30.000 | 30.000 | |||||
| 2019-03-05 | 2019-03-04 | 4 | Glover Nicholas | SRRA | Stock Option (right to buy) | D | 1,96 | 607.500 | 607.500 | |||||
| 2019-03-05 | 2019-03-04 | 4 | Hassig Christian | SRRA | Stock Option (right to buy) | D | 1,96 | 155.000 | 155.000 | |||||
| 2019-03-05 | 2019-03-04 | 4 | Jagpal Sukhi | SRRA | Stock Option (right to buy) | D | 1,96 | 200.000 | 200.000 | |||||
| 2019-03-05 | 2019-03-04 | 4 | Klencke Barbara | SRRA | Stock Option (right to buy) | D | 1,96 | 200.000 | 200.000 | |||||
| 2019-03-05 | 2019-03-04 | 4 | Kowalski Mark | SRRA | Stock Option (right to buy) | D | 1,96 | 200.000 | 200.000 | |||||
| 2018-12-11 | 2018-12-10 | 4 | Allen Andrew R | SRRA | Common Stock | D | 1,6400 | 66.000 | 108 | 66.000 | ||||
| 2018-06-14 | 2018-06-12 | 4 | Pelzer Robert | SRRA | Stock Option (right to buy) | D | 3,27 | 25.000 | 25.000 | |||||
| 2018-06-14 | 2018-06-12 | 4 | ESTES DANIEL | SRRA | Stock Option (right to buy) | D | 3,27 | 25.000 | 25.000 | |||||
| 2018-06-14 | 2018-06-12 | 4 | Allen Andrew R | SRRA | Stock Option (right to buy) | D | 3,27 | 25.000 | 25.000 | |||||
| 2018-06-14 | 2018-06-12 | 4 | Cooper Jeffrey H | SRRA | Stock Option (right to buy) | D | 3,27 | 25.000 | 25.000 | |||||
| 2018-06-14 | 2018-06-12 | 4 | Nguyen Tran | SRRA | Stock Option (right to buy) | D | 3,27 | 25.000 | 25.000 | |||||
| 2018-06-14 | 2018-06-12 | 4 | ONETTO NICOLE | SRRA | Stock Option (right to buy) | D | 3,27 | 25.000 | 25.000 | |||||
| 2018-06-14 | 2018-06-12 | 4 | Parfet Donald R | SRRA | Stock Option (right to buy) | D | 3,27 | 25.000 | 25.000 | |||||
| 2018-03-07 | 2018-03-06 | 4 | Glover Nicholas | SRRA | Stock Option (right to buy) | D | 2,36 | 562.780 | 562.780 | |||||
| 2018-03-07 | 2018-03-06 | 4 | Hassig Christian | SRRA | Stock Option (right to buy) | D | 2,36 | 205.180 | 205.180 | |||||
| 2018-03-07 | 2018-03-06 | 4 | Jagpal Sukhi | SRRA | Stock Option (right to buy) | D | 2,36 | 180.360 | 180.360 | |||||
| 2018-03-07 | 2018-03-06 | 4 | Klencke Barbara | SRRA | Stock Option (right to buy) | D | 2,36 | 180.360 | 180.360 | |||||
| 2018-03-07 | 2018-03-06 | 4 | Kowalski Mark | SRRA | Stock Option (right to buy) | D | 2,36 | 155.000 | 155.000 | |||||
| 2018-03-07 | 2018-03-06 | 4 | You Angie | SRRA | Stock Option (right to buy) | D | 2,36 | 180.360 | 180.360 | |||||
| 2018-01-08 | 2018-01-04 | 4 | Parfet Donald R | SRRA | Common Stock | D | 1.380 | 77.235 | ||||||
| 2018-01-08 | 2018-01-04 | 4 | Parfet Donald R Apjohn Ventures, LLC | SRRA | Common Stock | I | -2.760 | 0 | ||||||
| 2018-01-08 | 2018-01-04 | 4 | Parfet Donald R Apjohn Ventures, LLC | SRRA | Common Stock | I | 1.068 | 2.760 | ||||||
| 2018-01-08 | 2018-01-04 | 4 | Parfet Donald R Apjohn Ventures, LLC | SRRA | Common Stock | I | 1.692 | 1.692 | ||||||
| 2018-01-08 | 2018-01-04 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | SRRA | Common Stock | I | 3.383 | 390.913 | ||||||
| 2017-11-13 | 2017-11-10 | 4 | Allen Andrew R | SRRA | Stock Option (Right to Buy) | D | 1,92 | 50.000 | 50.000 | |||||
| 2017-10-25 | 3 | Allen Andrew R | SRRA | No securities beneficially owned. | D | 0 | ||||||||
| 2017-06-14 | 2017-06-13 | 4 | Cooper Jeffrey H | SRRA | Stock Option (right to buy) | D | 1,13 | 25.000 | 25.000 | |||||
| 2017-06-14 | 2017-06-13 | 4 | Nguyen Tran | SRRA | Stock Option (right to buy) | D | 1,13 | 25.000 | 25.000 | |||||
| 2017-06-14 | 2017-06-13 | 4 | ONETTO NICOLE | SRRA | Stock Option (right to buy) | D | 1,13 | 25.000 | 25.000 | |||||
| 2017-06-14 | 2017-06-13 | 4 | Parfet Donald R | SRRA | Stock Option (right to buy) | D | 1,13 | 25.000 | 25.000 | |||||
| 2017-06-14 | 2017-06-13 | 4 | Pelzer Robert | SRRA | Stock Option (right to buy) | D | 1,13 | 25.000 | 25.000 | |||||
| 2017-05-30 | 2017-05-25 | 4 | ESTES DANIEL | SRRA | Stock Option (Right to Buy) | D | 1,20 | 50.000 | 50.000 | |||||
| 2017-04-11 | 3 | ESTES DANIEL | SRRA | No securities beneficially owned | D | 0 | ||||||||
| 2017-03-09 | 2017-03-08 | 4 | You Angie | SRRA | Common Stock | D | 1,4300 | 30.000 | 43 | 133.252 | ||||
| 2017-03-08 | 2017-03-06 | 4 | You Angie | SRRA | Stock Option (right to buy) | D | 1,45 | 70.000 | 70.000 | |||||
| 2017-03-08 | 2017-03-06 | 4 | Jagpal Sukhi | SRRA | Stock Option (right to buy) | D | 1,45 | 70.000 | 70.000 | |||||
| 2017-03-08 | 2017-03-06 | 4 | Klencke Barbara | SRRA | Stock Option (right to buy) | D | 1,45 | 70.000 | 70.000 | |||||
| 2017-03-08 | 2017-03-06 | 4 | Glover Nicholas | SRRA | Stock Option (right to buy) | D | 1,45 | 195.000 | 195.000 | |||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10.298.316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14.038.047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10.298.316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14.038.047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10.298.316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14.038.047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10.298.316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14.038.047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10.298.316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14.038.047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10.298.316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14.038.047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10.298.316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14.038.047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10.298.316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14.038.047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14.038.047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14.038.047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10.298.316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 14.038.047 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10.298.316 | ||||||||
| 2017-02-24 | 3 | Heron Patrick J | SRRA | Common Stock | D | 10.298.316 | ||||||||
| 2017-02-16 | 2017-02-14 | 4 | Topper James N By Frazier Life Sciences VIII, L.P. | SRRA | Common Stock | I | 1,3500 | 5.925.926 | 8.000 | 5.925.926 | ||||
| 2017-01-04 | 3 | Kowalski Mark | DNAI | No securities beneficially held | D | 0 | ||||||||
| 2017-01-04 | 2017-01-03 | 4 | Kowalski Mark | DNAI | Stock Option (right to buy Class A Common Stock) | D | 1,54 | 300.000 | 300.000 | |||||
| 2016-11-10 | 2016-11-08 | 4 | Parfet Donald R | DNAI | Common Stock | D | 2.403 | 75.855 | ||||||
| 2016-11-10 | 2016-11-08 | 4 | Parfet Donald R Apjohn Ventures, LLC | DNAI | Common Stock | I | -4.806 | 0 | ||||||
| 2016-11-10 | 2016-11-08 | 4 | Parfet Donald R Apjohn Ventures, LLC | DNAI | Common Stock | I | 1.423 | 4.806 | ||||||
| 2016-11-10 | 2016-11-08 | 4 | Parfet Donald R Apjohn Ventures, LLC | DNAI | Common Stock | I | 3.383 | 3.383 | ||||||
| 2016-11-10 | 2016-11-08 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Common Stock | I | 6.767 | 387.530 | ||||||
| 2016-10-04 | 2016-09-30 | 4 | Jagpal Sukhi | DNAI | Stock Option (right to buy) | D | 1,82 | 168.000 | 168.000 | |||||
| 2016-10-04 | 2016-09-30 | 4 | Glover Nicholas | DNAI | Stock Option (right to buy) | D | 1,82 | 500.000 | 500.000 | |||||
| 2016-10-04 | 2016-09-30 | 4 | Klencke Barbara | DNAI | Stock Option (right to buy) | D | 1,82 | 456.000 | 456.000 | |||||
| 2016-10-04 | 2016-09-30 | 4 | You Angie | DNAI | Stock Option (right to buy) | D | 1,82 | 200.000 | 200.000 | |||||
| 2016-09-30 | 2016-09-29 | 4 | Parfet Donald R | DNAI | Common Stock | D | 1.202 | 73.452 | ||||||
| 2016-09-30 | 2016-09-29 | 4 | Parfet Donald R By Apjohn Ventures, LLC | DNAI | Common Stock | I | -2.403 | 0 | ||||||
| 2016-09-30 | 2016-09-29 | 4 | Parfet Donald R By Apjohn Ventures, LLC | DNAI | Common Stock | I | 711 | 2.403 | ||||||
| 2016-09-30 | 2016-09-29 | 4 | Parfet Donald R By Apjohn Ventures, LLC | DNAI | Common Stock | I | 1.692 | 1.692 | ||||||
| 2016-09-30 | 2016-09-29 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Common Stock | I | 3.384 | 380.763 | ||||||
| 2016-06-20 | 2016-06-16 | 4 | ONETTO NICOLE | DNAI | Stock Option (right to buy) | D | 2,06 | 38.835 | 38.835 | |||||
| 2016-06-20 | 2016-06-16 | 4 | Pelzer Robert | DNAI | Stock Option (right to buy) | D | 2,06 | 38.835 | 38.835 | |||||
| 2016-06-20 | 2016-06-16 | 4 | Parfet Donald R | DNAI | Stock Option (right to buy) | D | 2,06 | 38.835 | 38.835 | |||||
| 2016-06-20 | 2016-06-16 | 4 | Topper James N | DNAI | Stock Option (right to buy) | D | 2,06 | 38.835 | 38.835 | |||||
| 2016-06-13 | 2016-06-09 | 4 | Cooper Jeffrey H | DNAI | Stock Option (right to buy) | D | 2,06 | 77.670 | 77.670 | |||||
| 2016-06-13 | 2016-06-09 | 4 | Nguyen Tran | DNAI | Stock Option (right to buy) | D | 2,06 | 77.670 | 77.670 | |||||
| 2016-05-17 | 2016-05-13 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Common Stock | I | 3.204 | 377.379 | ||||||
| 2016-03-24 | 3 | Nguyen Tran | DNAI | No securities beneficially held | D | 0 | ||||||||
| 2016-03-24 | 3 | Cooper Jeffrey H | DNAI | No securities beneficially held | D | 0 | ||||||||
| 2016-03-24 | 2016-03-22 | 4 | Chapman Wendy | DNAI | Stock Option (right to buy) | D | 0,97 | -3.000 | 76.248 | |||||
| 2016-03-24 | 2016-03-22 | 4 | Chapman Wendy | DNAI | Common Stock | D | 7,0078 | -3.000 | -21 | 0 | ||||
| 2016-03-24 | 2016-03-22 | 4 | Chapman Wendy | DNAI | Common Stock | D | 0,9690 | 3.000 | 3 | 3.000 | ||||
| 2016-03-10 | 2016-03-08 | 4 | Messmann Richard A | DNAI | Stock Option (right to buy) | D | 6,58 | 25.000 | 25.000 | |||||
| 2016-03-10 | 2016-03-08 | 4 | Lovejoy Chandra D | DNAI | Stock Option (right to buy) | D | 6,58 | 31.000 | 31.000 | |||||
| 2016-03-10 | 2016-03-08 | 4 | Jagpal Sukhi | DNAI | Stock Option (right to buy) | D | 6,58 | 48.750 | 48.750 | |||||
| 2016-03-10 | 2016-03-08 | 4 | Glover Nicholas | DNAI | Stock Option (right to buy) | D | 6,58 | 161.250 | 161.250 | |||||
| 2016-03-10 | 2016-03-08 | 4 | Klencke Barbara | DNAI | Stock Option (right to buy) | D | 6,58 | 82.500 | 82.500 | |||||
| 2016-03-10 | 2016-03-08 | 4 | Chapman Wendy | DNAI | Stock Option (right to buy) | D | 6,58 | 25.000 | 25.000 | |||||
| 2016-03-10 | 2016-03-08 | 4 | You Angie | DNAI | Stock Option (right to buy) | D | 6,58 | 75.000 | 75.000 | |||||
| 2016-02-24 | 2016-02-22 | 4 | Chapman Wendy | DNAI | Stock Option (right to buy) | D | 0,97 | -3.000 | 79.248 | |||||
| 2016-02-24 | 2016-02-22 | 4 | Chapman Wendy | DNAI | Common Stock | D | 7,0600 | -3.000 | -21 | 0 | ||||
| 2016-02-24 | 2016-02-22 | 4 | Chapman Wendy | DNAI | Common Stock | D | 0,9690 | 3.000 | 3 | 3.000 | ||||
| 2016-01-25 | 2016-01-22 | 4 | Chapman Wendy | DNAI | Stock Option (right to buy) | D | 0,97 | -5.000 | 82.248 | |||||
| 2016-01-25 | 2016-01-22 | 4 | Chapman Wendy | DNAI | Common Stock | D | 9,3946 | -5.000 | -47 | 0 | ||||
| 2016-01-25 | 2016-01-22 | 4 | Chapman Wendy | DNAI | Common Stock | D | 0,9690 | 5.000 | 5 | 5.000 | ||||
| 2016-01-22 | 2016-01-22 | 4 | Rodigueza Wendi | DNAI | Common Stock | D | 9,6600 | -1.000 | -10 | 156.276 | ||||
| 2016-01-22 | 2016-01-21 | 4 | Rodigueza Wendi | DNAI | Common Stock | D | 10,3230 | -1.000 | -10 | 157.276 | ||||
| 2016-01-22 | 2016-01-20 | 4 | Rodigueza Wendi | DNAI | Common Stock | D | 9,5900 | -1.000 | -10 | 158.276 | ||||
| 2016-01-19 | 2016-01-15 | 4 | Glover Nicholas | DNAI | Stock Option (right to buy) | D | 0,97 | -5.000 | 864.219 | |||||
| 2016-01-19 | 2016-01-15 | 4 | Glover Nicholas | DNAI | Common Stock | D | 10,0446 | -5.000 | -50 | 0 | ||||
| 2016-01-19 | 2016-01-15 | 4 | Glover Nicholas | DNAI | Common Stock | D | 0,9690 | 5.000 | 5 | 5.000 | ||||
| 2016-01-14 | 2016-01-12 | 4 | Lovejoy Chandra D | DNAI | Stock Option (right to buy) | D | 0,97 | -7.551 | 46.140 | |||||
| 2016-01-14 | 2016-01-12 | 4 | Lovejoy Chandra D | DNAI | Common Stock | D | 11,9282 | -5.562 | -66 | 0 | ||||
| 2016-01-14 | 2016-01-12 | 4 | Lovejoy Chandra D | DNAI | Common Stock | D | 11,0628 | -15.411 | -170 | 5.562 | ||||
| 2016-01-14 | 2016-01-12 | 4 | Lovejoy Chandra D | DNAI | Common Stock | D | 0,9690 | 7.551 | 7 | 20.973 | ||||
| 2015-12-02 | 3 | Anderson Keith Edward | DNAI | No securities are beneficially owned | D | 0 | ||||||||
| 2015-12-02 | 2015-12-01 | 4 | Anderson Keith Edward | DNAI | Stock Option (right to buy) | D | 18,33 | 100.000 | 100.000 | |||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Series D Preferred Stock | I | -287.631 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Series C Preferred Stock | I | -471.242 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Series C Preferred Stock | I | -38.824 | 471.242 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Series C Preferred Stock | I | 126.558 | 510.066 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Series C Preferred Stock Warrant (right to buy) | I | 5,2150 | -126.558 | -660 | 0 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Common Stock | I | 5,2150 | 39.889 | 208 | 798.762 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Common Stock | I | 287.631 | 758.873 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Vitangcol Alvin By Capital Midwest Fund II, L.P. | DNAI | Common Stock | I | 471.242 | 471.242 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Topper James N By Frazier Healthcare VI, L.P. | DNAI | Series D Preferred Stock | I | -1.869.606 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Topper James N By Frazier Healthcare VI, L.P. | DNAI | Common Stock | I | 17,0000 | 220.000 | 3.740 | 2.186.195 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Topper James N By Frazier Healthcare VI, L.P. | DNAI | Common Stock | I | 5,2150 | 96.589 | 504 | 1.966.195 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Topper James N By Frazier Healthcare VI, L.P. | DNAI | Common Stock | I | 1.869.606 | 1.869.606 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Thompson Peter A. See Footnotes | DNAI | Series D Preferred Stock | I | -1.725.790 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Thompson Peter A. See Footnotes | DNAI | Common Stock | I | 17,0000 | 175.000 | 2.975 | 1.989.949 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Thompson Peter A. See Footnotes | DNAI | Common Stock | I | 5,2150 | 89.159 | 465 | 1.814.949 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Thompson Peter A. See Footnotes | DNAI | Common Stock | I | 1.725.790 | 1.725.790 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Rodigueza Wendi | DNAI | Series B-1 Preferred Stock | D | -1.966 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Rodigueza Wendi | DNAI | Common Stock | D | 1.966 | 159.276 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Palmero Group LLC | DNAI | Series C Preferred Stock | I | -13.130 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Palmero Group LLC | DNAI | Series A Preferred Stock | I | -46.034 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Series B-1 Preferred Stock | I | -142.422 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Series B Preferred Stock | I | -189.933 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Series A Preferred Stock | I | -306 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006 | DNAI | Series C Preferred Stock | I | -65.938 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006 | DNAI | Series B-1 Preferred Stock | I | -121.242 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006 | DNAI | Series B Preferred Stock | I | -23.944 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By wife | DNAI | Series A Preferred Stock | I | -4.415 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series C Preferred Stock | I | -24.277 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series C Preferred Stock | I | -221 | 24.277 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series C Preferred Stock | I | 719 | 24.498 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series C Preferred Stock Warrant (right to buy) | I | 5,2150 | -719 | -4 | 0 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series B-1 Preferred Stock | I | -516.203 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series B-1 Preferred Stock | I | -2.941 | 516.203 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series B-1 Preferred Stock | I | 6.711 | 519.144 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series B-1 Preferred Stock Warrant (right to buy) | I | 7,4500 | -6.711 | -50 | 0 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series B-1 Preferred Stock | I | -40.729 | 512.433 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R y Apjohn Ventures Fund, LP | DNAI | Series B-1 Preferred Stock | I | 265.536 | 553.162 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series B-1 Preferred Stock Warrant (right to buy) | I | 2,6080 | -265.536 | -693 | 0 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series B Preferred Stock | I | -153.485 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Series A Preferred Stock | I | -26.728 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Annex Fund LP | DNAI | Series D Preferred Stock | I | -11.505 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Annex Fund LP | DNAI | Series C Preferred Stock | I | -59.225 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Annex Fund LP | DNAI | Series B-1 Preferred Stock | I | -67.112 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Group, LLC | DNAI | Series A Preferred Stock | I | -307 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Palmero Group LLC | DNAI | Common Stock | I | 5,2150 | 819 | 4 | 65.779 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Palmero Group LLC | DNAI | Common Stock | I | 13.130 | 64.960 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Palmero Group LLC | DNAI | Common Stock | I | 51.830 | 51.830 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Common Stock | I | 142.422 | 353.802 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Common Stock | I | 211.036 | 211.380 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Donald R. Parfet 2006 Trust, Dated May 1, 2006 | DNAI | Common Stock | I | 344 | 344 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006 | DNAI | Common Stock | I | 5,2150 | 4.119 | 21 | 217.903 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006 | DNAI | Common Stock | I | 65.938 | 213.784 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006 | DNAI | Common Stock | I | 121.242 | 147.846 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Ann VanDeWater Parfet 2006 Revocable Trust, Dated May 5, 2006 | DNAI | Common Stock | I | 26.604 | 26.604 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By wife | DNAI | Common Stock | I | 4.970 | 4.970 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Common Stock | I | 5,2150 | 1.552 | 8 | 770.045 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Common Stock | I | 24.277 | 768.493 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Common Stock | I | 516.203 | 744.216 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Common Stock | I | 170.538 | 228.013 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Common Stock | I | 30.093 | 57.475 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Annex Fund LP | DNAI | Common Stock | I | 5,2150 | 4.413 | 23 | 142.255 | ||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Annex Fund LP | DNAI | Common Stock | I | 11.505 | 137.842 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Annex Fund LP | DNAI | Common Stock | I | 59.225 | 126.337 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Ventures Annex Fund LP | DNAI | Common Stock | I | 67.112 | 67.112 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | Parfet Donald R By Apjohn Group, LLC | DNAI | Common Stock | I | 345 | 589 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Series D Preferred Stock | I | -44.991 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures Fund VII, L.P. | DNAI | Series D Preferred Stock | I | -2.064.308 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Common Stock | I | 17,0000 | 4.693 | 80 | 2.438.270 | ||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures Fund VII, L.P. | DNAI | Common Stock | I | 17,0000 | 215.307 | 3.660 | 2.433.577 | ||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Common Stock | I | 5,2150 | 2.324 | 12 | 2.218.270 | ||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures Fund VII, L.P. | DNAI | Common Stock | I | 5,2150 | 106.647 | 556 | 2.215.946 | ||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Common Stock | I | 44.991 | 2.109.299 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | VIVO VENTURES VII, LLC By Vivo Ventures Fund VII, L.P. | DNAI | Common Stock | I | 2.064.308 | 2.064.308 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Series D Preferred Stock | I | -44.991 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures Fund VII, L.P. | DNAI | Series D Preferred Stock | I | -2.064.308 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Common Stock | I | 17,0000 | 4.693 | 80 | 2.438.270 | ||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures Fund VII, L.P. | DNAI | Common Stock | I | 17,0000 | 215.307 | 3.660 | 2.433.577 | ||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Common Stock | I | 5,2150 | 2.324 | 12 | 2.218.270 | ||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures Fund VII, L.P. | DNAI | Common Stock | I | 5,2150 | 106.647 | 556 | 2.215.946 | ||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures VII Affiliates Fund, L.P. | DNAI | Common Stock | I | 44.991 | 2.109.299 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | CHA ALBERT By Vivo Ventures Fund VII, L.P. | DNAI | Common Stock | I | 2.064.308 | 2.064.308 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | ORBIMED ADVISORS LLC See Footnotes | DNAI | Series D Preferred Stock | I | -1.725.790 | 0 | ||||||
| 2015-07-21 | 2015-07-21 | 4 | ORBIMED ADVISORS LLC See Footnotes | DNAI | Common Stock | I | 17,0000 | 175.000 | 2.975 | 1.989.949 | ||||
| 2015-07-21 | 2015-07-21 | 4 | ORBIMED ADVISORS LLC See Footnotes | DNAI | Common Stock | I | 5,2150 | 89.159 | 465 | 1.814.949 | ||||
| 2015-07-21 | 2015-07-21 | 4 | ORBIMED ADVISORS LLC See Footnotes | DNAI | Common Stock | I | 1.725.790 | 1.725.790 | ||||||
| 2015-07-15 | 3 | You Angie | DNAI | Common Stock | D | 206.504 | ||||||||
| 2015-07-15 | 3 | You Angie | DNAI | Common Stock | D | 206.504 | ||||||||
| 2015-07-15 | 3 | Rodigueza Wendi | DNAI | Common Stock | D | 314.620 | ||||||||
| 2015-07-15 | 3 | Rodigueza Wendi | DNAI | Common Stock | D | 314.620 | ||||||||
| 2015-07-15 | 3 | Messmann Richard A | DNAI | Common Stock | D | 80.104 | ||||||||
| 2015-07-15 | 3 | Messmann Richard A | DNAI | Common Stock | D | 80.104 | ||||||||
| 2015-07-15 | 3 | Lovejoy Chandra D | DNAI | Common Stock | D | 26.844 | ||||||||
| 2015-07-15 | 3 | Lovejoy Chandra D | DNAI | Common Stock | D | 26.844 | ||||||||
| 2015-07-15 | 3 | Parfet Donald R By Apjohn Group, LLC | DNAI | Common Stock | I | 97.718 | ||||||||
| 2015-07-15 | 3 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Common Stock | I | 124.856 | ||||||||
| 2015-07-15 | 3 | Parfet Donald R By Apjohn Ventures Fund, LP | DNAI | Common Stock | I | 124.856 | ||||||||
| 2015-07-15 | 3 | Parfet Donald R By Apjohn Group, LLC | DNAI | Common Stock | I | 97.718 | ||||||||
| 2015-07-15 | 3 | Parfet Donald R | DNAI | Common Stock | D | 167.322 | ||||||||
| 2015-07-15 | 3 | Parfet Donald R | DNAI | Common Stock | D | 167.322 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
